✦ LIBER ✦

Immunosuppression in toxoplasmosis: Studies in mice with a clostridial vaccine and louping-ill virus vaccine

✍ Scribed by D. Buxton; H.W. Reid; I. Pow

Book ID: 115963358
Publisher: Elsevier Science
Year: 1979
Tongue: English
Weight: 348 KB
Volume: 89
Category: Article
ISSN: 0021-9975
DOI: 10.1016/0021-9975(79)90027-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunosuppression in toxoplasmosis: Prel

Immunosuppression in toxoplasmosis: Preliminary studies in mice infected with louping-ill virus

✍ D. Buxton; H.W. Reid; J. Finlayson; I. Pow 📂 Article 📅 1980 🏛 Elsevier Science 🌐 English ⚖ 450 KB

Immunosuppression in toxoplasmosis: Stud

Immunosuppression in toxoplasmosis: Studies in lambs and sheep infected with louping-ill virus

✍ H.W. Reid; D. Buxton; A.C. Gardiner; I. Pow; J. Finlayson; M.J. MacLean 📂 Article 📅 1982 🏛 Elsevier Science 🌐 English ⚖ 629 KB

Immunosuppression in bovine trypanosomia

Immunosuppression in bovine trypanosomiasis: Field studies using foot-and-mouth disease vaccine and clostridial vaccine

✍ J. M. Scott; R. G. Pegram; P. H. Holmes; T. W. F. Pay; P. A. Knight; F. W. Jenni 📂 Article 📅 1977 🏛 Springer Netherlands 🌐 English ⚖ 600 KB

A recombinant Semliki Forest virus parti

A recombinant Semliki Forest virus particle vaccine encoding the prME and NS1 proteins of louping ill virus is effective in a sheep challenge model

✍ Margaret M Morris-Downes; Brian J Sheahan; Marina N Fleeton; Peter Liljeström; H 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 695 KB

Development of a recombinant tetravalent

Development of a recombinant tetravalent dengue virus vaccine: Immunogenicity and efficacy studies in mice and monkeys

✍ David E. Clements; Beth-Ann G. Coller; Michael M. Lieberman; Steven Ogata; Gordo 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 292 KB

Studies in man with a cold-recombinant l

Studies in man with a cold-recombinant live influenza b virus vaccine

✍ P. Reeve; M. Pibermann; H. Bachmayer; E. Liehl; A. Moritz; U. Ganzinger; H. Hofm 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 399 KB

## Abstract A cold recombinant live influenza B virus vaccine was tested in man. In comparison to a placebo, reactogenicity attributable to virus infection was slight or moderate. No revertant viruses were shed, and there was no evidence of transmission to the placebo group who were housed in close